For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Top Early Stage Professionals (ESP) Abstracts
Sunday, September 10, 2023 09:15 AM - 10:15 AM  
Grand Ballroom L
Chair
Rachel Burga, PhD, Obsidian Therapeutics, USA

Presenters
  • Kyong Hoon AnhNext-generation Mesenchymal Stromal Cell Therapy: Human Pluripotent Stem Cells Genetically Engineered to express AFFIMER® proteins to Enhance the Immune Response
  • Luke Haines Characterization of the NanoSpark™ GROW-NK Soluble Activator, a Feeder Cell and Magnetic Bead-Free Natural Killer Cell Expansion Technology
  • Maksim MamonkinCD5 CAR T-cells promote selection of CD5-negative circulating T-cells avoiding global T-cell aplasia
  • Nicholas McMahonA Scalable 3D Printed Bioreactor for The Expansion of Anchorage-Dependent Cells and Production of Cell-Derived Biologics
  • Jessica MurphyAllogeneic, Leukopheresis-Derived, Virus-Specific T Cell Therapy for BK Nephropathy Post Kidney Transplant: Phase I Manufacturing Experience – Initial 3 Patients
  • Rebecca VaughtAdvancing Cell Therapies through a Novel Omics-Based Approach for Culture Media Optimization

Rachel Burga PhD
Principal Scientist
Obsidian Therapeutics
Chair